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ABSTRACT 
THE TRENDS AND DISPARITIES IN THE DIAGNOSIS OF BREAST CANCER BY 
MOBILE MAMMOGRAPHY AT A COMPREHENSIVE CANCER CENTER 
Dianhong Luo 
April 5, 2012 
This study used the de-identified breast cancer screen data which recorded the 
information of 58231 screens and 22534 participants with different background. The 
analysis of disparities on age, ethnic, health insurance and screen location has been done 
based on screen and participant number. Women younger than 50 or white, or the women 
without insurance are most likely to take the screen. The percentages are 40%,64% and 
40% under each category. The most popular location for screen is partnership clinic, 
which comprise 43% of screens. The year 2006 has the most screens which is 6861, and 
2001 has the least which is 4813. The trend over the years and the disparities of 
pathology results were assessed. Chi-square test was performed to check the association. 
The odds ratios based on participants number are calculated. For race/insurance, in age 
groups "50-", "50-59" and "70+", the odds of white people with insurance is about 1.7, 
1.9 and 0.4 of black people with insurance. No difference was found in age group "60-69'. 
For race/pathology result, the significant result is only for age group "70+", and the odds 
of white women with "Negative" pathology result is 4.4 times of black women with 
"Negative" pathology result. Besides, for insurance/pathology result, the odds of women 
with insurance "Yes" having "Negative" pathology result are 2.26 and 2,08 times ofthe 
v 
women with insurance "Yes" having "Negative" pathology result for age group "50-" and 
"50-59".The follow-up study was presented in this thesis. The maximum number that 
each person took the screen is 17. The majority (45%) only take screen once. About 19% 
of women take twice, 12% take triple. Only 1 woman takes 17 times. Pearson and 
Spearman correlation coefficients were calculated to check the association. 
VI 
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Breast cancer is the most common cancer among American women, except for skin 
cancers. The chance of developing invasive breast cancer at some time in a woman's life 
is a little less than 1 in 8 (12%). The American Cancer Society's most recent estimates for 
breast cancer in the United States are for 2012 [1]: 
• About 226,870 new cases of invasive breast cancer will be diagnosed in 
women. 
• About 63,300 new cases of carcinoma in situ (CIS) will be diagnosed (CIS is 
non-invasive and is the earliest form of breast cancer). 
• About 39,510 women will die from breast cancer 
The risk for breast cancer increases with age and several other factors which include 
genetic history, obesity, not or late child bearing, early menarche, and late menopause [2]. 
The incidence of breast cancer (ductal carcinoma in situ (DC IS) and invasive breast 
cancer) has risen substantially over the past 20 years [3-4], in parallel with increasing use 
of screening mammography. But the female breast cancer incidence rates decreased by 
about 2% per year from 1999 to 2005. This decrease was seen only in women aged 50 or 
older, and may be due at least in part to the decline in use of hormone therapy after 
menopause. 
Breast cancer is also the second leading cause of cancer death in women, 
exceeded only by lung cancer. The chance that breast cancer will be responsible for a 
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woman's death is about 1 in 36 (about 3%). Death rates from breast cancer have been 
declining since about 1990, with larger decreases in women younger than 50. These 
decreases are believed to be the result of earlier detection through screening and 
increased awareness, as well as improved treatment. 
Cancer-related organizations such as the American Medical Association, the 
American College of Obstetricians and Gynecologists (ACOG), and the American 
Cancer Society recommend that women age 40 and older have a mammogram every year. 
The Health People 2010 (HP20 1 0) planed to have 70% of women over 40 years old with 
mammogram. But some states have not achieved the objective [5]. The breast cancer 
screening rate has been increasing steadily since the 1990s but fell slightly between 1999 
and 2002 [6]. This drop in the screening rate raised the concern that breast cancer 
occurrence and mortality rates might increase. Moreover, despite the overall increase in 
the screening rate, disparities based on race, age, education, income or social class still 
exist in breast cancer screening [7-10]. Understanding the strong association between 
demographic position and the breast cancer screening rate may provide insight into 
improving the screening rate. 
Several studies in other countries have revealed disparities between population 
subgroups at each phase of breast cancer [11-13]. Although disparities in screening 
mammography have improved overall since the early 1990s, significant differences in 
screening persist among many medically underserved communities. Vulnerable 
populations such as racial/ethnic minorities, the elderly, and the poor are more likely to 
be uninsured and lack a usual source of care. Compared to their middle-class and wealthy 
counterparts, low-income women have the lowest rates of breast cancer screening, even 
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when adjusted for race, ethnicity, and insurance status [14-16]. Low socioeconomic status 
(SES) is a consistent marker for mammography underuse; 
All racial/ethnic minorities in the U.S. have been documented underutilization of 
preventive health services that reflect sociodemographic variables, cultural barriers, and 
health systems obstacles. National Health Interview Survey (NHIS) describes new 
immigrants as the latest subpopulation of women with low rates of mammography use. 
Only 39.3% of women living in the U.S. for less than 10 years reported having a 
mammogram within the prior 2 years, in comparison to 64.7% of women living in the 
U.S. for 10 years or more and 71.3% of women born in the U.S. [17] Immigrants are 
disproportionately members of racial/ethnic minorities, making these women at 
particularly high risk for underuse of mammography. Besides, the black women in USA 
receive less mammography than white women even with similar use of primary care. A 
study showed black women were more likely to not undergo mammography (odds ratio 
[OR], 3.00 [95% CI, 2.41 to 3.75]) and to be given a diagnosis oflate-stage disease (OR, 
2.49 [CI, 1.59 to 3.92]) than white women [18]. Although some research suggests that 
this gap may be narrowing [19], the difference in use of mammography between black 
women and white women persists. Having a regular provider or source of health care is 
the most important determinant of mammography use [20-21]. Whites, younger women, 
and women with higher incomes and more education are consistently more likely to use 
mammography. Although the effect is more modest than that of the other factors, having 
insurance that covers the cost of mammography has been shown to increase the use of 
mammography. For both black and white women, greater mammography use was 
associated with more visits to a primary care physician. The deficit for black women 
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persisted at each socioeconomic status, even after use of primary care was considered. 
The number of primary care visits did less to "boost" mammography use for black 
women than for white women. Thus, although the number of visits made to a primary 
care physician does influence mammography use, it is not sufficient to overcome 
socioeconomic and regional differences in mammography use. These results suggest that 
the nature of primary care may vary within and among states and between black women 
and white women. 
Age is another cause of disparities in mammography. Women aged 65 years and 
older comprise or.ly 14% of women in the United States, nearly half (47%) of breast 
cancer cases diagnosed annually and more than half (53%) of breast cancer mortality 
occurs in this age group [22-23]. Despite increased risk and evidence suggesting that 
mammography's mortality benefits can extend to elderly populations, older women are 
less likely to be screened [24-25]. There has been little research addressing whether 
mammography is effective in decreasing breast cancer mortality in these women. This is 
due, in part, to competing risks of death and limited life expectancy; although elderly 
women have the highest risk of breast cancer, they are actually more likely to die of 
cardiovascular disease than malignancy [26]. Conflicting recommendations by various 
organizations about the age to stop mammographic screening reflect the uncertainty 
about the benefits of screening mammography in older women [27-31]. Numerous 
studies verify that women age 70 and older have lower rates of mammography compared 
to those between 50 and 69 years of age [32-33]. 
Women who live in rural areas are the one of subgroups for under-screening. 
Previous studies have suggested that women living in rural areas of the United States may 
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use preventive health care services less frequently than women living in urban areas of 
the country [34]. Studies also have found that women living in rural areas are less likely 
than those living in urban areas to have had a recent mammogram or Papanicolau (Pap) 
test [35-36]. Furthermore, women in rural areas of the United States have been found to 
have higher rates of breast carcinoma and late-stage disease than women in non-rural 
areas [37]. Possible explanations to account for the less frequent use of preventive 
services by rural women, compared with non-rural women include they are more likely to 
be uninsured, have a low household income, and be less educated; they are at particular 
risk of preventive care underutilization compared to women in non-rural regions. A 
research showed [38] that women residing in rural areas of the US are screened for breast 
cancer at a significantly lower rate than women in urban areas (66.7% vs. 75.4%). Many 
rural regions are characterized by longer distances between medical facilities and less 
availability of health services, subsequently limiting access to breast cancer screening 
[39]. Tn addition, studies suggest that screening disparities between rural and non-rural 
populations are more pronounced among minorities. For example, rural ethnic subgroups 
such as African-American and Native-American women have been found to receive less 
cancer screening than their non-rural counterparts [40]. 
The United States may be farther from its national goals of screening 
mammography, particularly among underserved women. Over the past two decades, 
health agencies on the federal and state level have made efforts to increase 
mammography use through outreach programs to those underserved women. The 
disparities of mammography screen have been improved, but the significant differences 
persist in the patterns of mammography by race /ethnicity, age, demographic, 
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socioeconomic, and health system variables. The cause of breast cancer disparities is 
comprehensive. A study must define and character the groups that have fewer screening. 
Most previous studies have observed the differences among cross-sectional disparities 
factors. However, continued monitoring of population-based trends and variations in 
breast cancer screening use by demographic position is needed. This study assessed the 
difference in the breast cancer screen according to women vs. socioeconomic position 
and examined the trends in breast cancer screen by observing differences in age, health 
insurance system, and racial demographics over 10 years period. The study explores the 
various barriers to mammography, with special attention to the unique needs of different 
populations. Despite the heterogeneity of medically underserved women, many of the 
barriers are common to different populations and reflect limited access to health 
information and services. 
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CHAPTER II 
DATA AND ANALYSIS METHODS 
1. Data sources 
The De-identified breast cancer screen data were taken from 2001-2010 by James 
Graham Brown Cancer Center. The subjects are civilian, non-institutionalized adults aged 
18 older. The purpose is to find the trends and disparities of impact of mobile 
mammography on the diagnosis of breast cancer. The screen is performed at 236 
locations in state of Kentucky. If any abnormal is found, a further exam like ultrasound or 
biopsy is performed. A total of22534 women enter the program and some of them take 
multiple screens, so make a total of 58231 screens within 10 years. 
The data set includes 14 variables that are patient study number, Corporate or 
Partnership Clinic or Partnership Community, Age, Comp date, Hispanic(Hispanic Y, N, 
Unknown), Ethnic, CPT, CPT name, Assessment, Rec Desc (description),Pathology, 
pathology code, Insured or uninsured, lost to FlU. The purpose of the thesis is to identify 
the disparities of people who participates the mammography screen based on race, age, 
insurance system and residual area. So we limit our analysis to those key variables such 
as location, age-group, ethnic, and insured. 
Laura Fry and Dr. Sarah Mizuguchi classified the 236 screen locations into 3 
categories under variable "location": Corporate, Partnership Clinic, and Partnership 
Community, and 25 insurance companies into 3 categories under variable "insured": 
Uninsured, Private insured and Public insured, which makes the job easier. The variable 
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Table 1 
Summary of De-identified breast cancer screen data 
Variable Value Frequency Percent of Total 
Count Frequency 
Insured Uninsured 22997 39.5532 
Private Insured 21062 36.2251 
Public Insured 14083 24.2217 
Location PARTNERSHIP CLINIC 25284 43.4866 
CORPORATE 19319 33.2273 
PARTNERSHIP COMMUNITY 13539 23.2861 
age group 50- 23073 39.6839 
50-59 19044 32.7543 
60-69 10291 17.6998 
70+ 5734 9.8621 
Pathology code 0 57181 98.3472 
1 506 0.8703 
6 233 0.4007 
2 157 0.2700 
4 39 0.0671 
3 22 0.0378 
5 4 0.0069 
race White 37104 63.8162 
Black 16252 27.9523 
Other 4786 8.2316 
year 2006 6861 11.8004 
2005 6609 11.3670 
2004 6338 10.9009 
2003 6192 10.6498 
2007 5941 10.2181 
2002 5736 9.8655 
2010 5276 9.0743 
2008 5207 8.9557 
2009 5169 8.8903 
2001 4813 8.2780 
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"race" replacing "ethnic" includes 3 categorical data: "black", "white" and "other"; 
"Agegroup" replacing "age" has 4 data: "50-", "50-59", "60-69" and "70+". Among 
58231 screens, 89 screens are with missing or mistaken information and removed for 
analysis. It makes a total of 58142 screens for the following statistical analysis. The data 
structure is present in Table 1. 
2. Analysis methods 
SAS (V9.2) and SAS enterprise were used to analysis the De-identified breast cancer 
screen data. At first the analysis based on screen number was done. The proportion of the 
screens based on 4 age groups, 3 races, 3 insurance systems, and 3 screen locations from 
2001-2010 is shown. The thesis also presents the disparities of screen frequency for 
different combinations and the disparities of pathology code based on age group, race, 
insurance system, and screen locations. Chi-square test to check the association (HO: 
Independent). Secondly, the analysis based on participants was performed which includes 
odds ratio calculation, CMH tests to check the conditional independence, the follow-up 





Table 2 shows the general characteristics of the study population. The distribution 
and the percentage of demographic characteristics from the beginning (2001) to ending 
(2010) years are presented. Women aged less than 50 years old are more likely to take the 
screen (39.68%). Aged group from 50-59 is 2nd (32.75%), followed by age group 60-69 
(17.70%), women older than 70 years is the last (9.86%); White women who go to screen 
are about twice more than black women (63.82% for white vs. 27.95% for black), women 
with other race are the least (8.23%). The screen percentage of39.55% for uninsured 
women is little higher than the percentage of 36.23 % for private insured women, the 
public insured women only have 24.22%. For location, people are more likely going to 
partnership clinical (43.49%), then corporate (33.23%). The last one is partnership 
community (23.39%). The year of 2006 has the highest percentage of 11.80%, 2001 has 
the lowest one 8.28%. 
Figures 1-3 are the diagrams of screen frequency of age group from 2001 to 2010 
for different race. The trend patterns for all races are the same: the older group, the less 
frequency. So the highest frequency is for age group less than 50 and lowest frequency is 
for age group older than 70. For black, the highest frequency is 835 which happened in 
2003, the lowest is 78 in 2007; for white, the highest is 1633 in the year of 2004, the 
lowest is 248 in the year of 2009; For other, the highest number is 593 in 2007, and the 
lowest number is 4 in 2001. 
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Table 2 
Proportion of Participants in the breast cancer screens 
year 
Age group (count/percent) 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Total 
50- 1956 2350 2477 2550 2656 2652 2312 2037 2065 2018 23073 
3.36 4.04 4.26 4.39 4.57 4.56 3.98 3.50 3.55 3.47 39.68 
50-59 1483 1725 1920 1954 2056 2279 2063 1799 1836 1929 19044 
2.55 2.97 3.30 3.36 3.54 3.92 3.55 3.09 3.16 3.32 32.75 
60-69 903 1043 1114 1136 1123 1165 1031 935 901 940 10291 
1.55 1.79 1.92 1.95 1.93 2.00 1.77 1.61 1.55 1.62 17.70 
70+ 471 618 681 698 774 765 535 436 367 389 5734 
0.81 1.06 1.17 1.20 1.33 1.32 0.92 0.75 0.63 0.67 9.86 
Race 
Black 1517 1762 2018 1919 2060 2070 995 1115 1373 1423 16252 
2.61 3.03 3.47 3.30 3.54 3.56 1.71 1.92 2.36 2.45 27.95 
Other 148 157 189 263 485 493 1324 882 374 471 4786 
0.25 0.27 0.33 0.45 0.83 0.85 2.28 1.52 0.64 0.81 8.23 
White 3148 3817 3985 4156 4064 4298 3622 3210 3422 3382 37104 
5.41 6.56 6.85 7.15 6.99 7.39 6.23 5.52 5.89 5.82 63.82 
Insured 
Private 1839 1950 2023 2133 2401 2506 2159 1978 2101 1972 21062 
Insured 3.16 3.35 3.48 3.67 4.13 4.31 3.71 3.40 3.61 3.39 36.23 
Public 1150 1414 1667 1699 1846 1817 1430 1130 957 973 14083 
Insured 1.98 2.43 2.87 2.92 3.17 3.13 2.46 1.94 1.65 1.67 24.22 
Uninsur 1824 2372 2502 2506 2362 2538 2352 2099 2111 2331 22997 
ed 3.14 4.08 4.30 4.31 4.06 4.37 4.05 3.61 3.63 4.01 39.55 
Location 
Corporate 1883 2121 2147 2134 2200 2326 1785 1539 1661 1523 19319 
3.24 3.65 3.69 3.67 3.78 4.00 3.07 2.65 2.86 2.62 33.23 
Partnership 1976 2535 2757 2748 2882 3007 2723 2518 2122 2016 25284 
clinic 3.40 4.36 4.74 4.73 4.96 5.17 4.68 4.33 3.65 3.47 43.49 
Partnership 954 1080 1288 1456 1527 1528 1433 1150 1386 1737 13539 
community 1.64 1.86 2.22 2.50 2.63 2.63 2.46 1.98 2.38 2.99 23.29 
Total 4813 5736 6192 6338 6609 6861 5941 5207 5169 5276 58142 
8.28 9.87 10.65 10.90 11.37 11.80 10.22 8.96 8.89 9.07 100.00 
Figures 4-6 are the diagrams of screen frequency from 2001-2010 for age group 
with different insurance system. The patterns of "private insured" and 'uninsured' are the 
same, but the pattern of "public insured" is reversed. It is understandable because "public 
11 
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Figure 1. Screen frequency of age group over 10 years for race = black 
Frequency 





Figure 3. Screen frequency of age group over 10 years for race = other 
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insured" are Medicare and medicaid which are always issued to older women. For 
"private insured", the highest number is 1174 for women younger than 50 and in year 
2005, the lowest is 34 for women older than 70 and in year 2004. For "public insured", 
the highest one is 709 for women older than 70 and in year 2005, the lowest one is 168 
for women younger than 50 and in year 2001 . For "uninsured", the highest is 1235 for 
people less than 50 and in the year of 2006, the lowest is 6 for people older than 70 and in 
year of2010. 






Figure 4. Screen frequency of age group over 10 years at insured = private insured 
Frequency 
agegroup 




Figure 6. Screen frequency of agegroup over 10 years at insured = uninsured 
Figures 7-9 are the diagrams of screen frequency for different age group at 
different location. The patterns of "corporate" or "partnership clinic" or "partnership 
community" are similar. The highest frequency always happens for age group "50-" and 
the lowest frequency is for age group "70+". So at location = "corporate", the highest 
count is 965 in year 2002 and lowest count is 92 in year 2010; at location = "partnership 
clinic", the highest is 1196 in 2006 and the lowest is 1 08 in 2010; at location = 












Figure 8. Screen frequency of age group over 10 years at location = partnership clinic 
Fre.quency 
Figure 9. Screen frequency of agegroup over 10 years at location=partnership community 
Another important concern is the disparities of pathology results of screens based 
on different insurance system, age groups, and races. As mentioned before, if any 
abnormal was found during the screen, a further exam was performed such as biopsy or 
ultrasound. The code (pathology code) represents seven different pathology results. 0 = 
"No Biopsy", 1 = "Benign", 2 = "CYST ASPIRATION", 3 = "Negative", 4 = "High 
Risk", 5 ="INCONCLUSIVE", and 6 = "MALIGNANT". Table 3 shows the frequency 
and percentage under different pathology code for all age groups, races, and insurance 
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Table 3 
Pathology result based on age group/race/insured 
Pathology Code 
Age group (count/percent of column) 
0 1 2 3 4 5 6 Total 
50- 22662 266 73 9 11 1 51 23073 
39.63 52.57 46.50 40.91 28.21 25.00 21.89 
50-59 18724 158 50 9 20 1 82 19044 
32.75 31.23 31.85 40.91 51.28 25.00 35.19 
60-69 10134 62 24 2 6 0 63 10291 
17.72 12.25 15.29 9.09 15.38 0.00 27.04 
70+ 5661 20 10 2 2 2 37 5734 
9.90 3.95 6.37 9.09 5.13 50.00 15.88 
Race 
Black 15953 141 52 9 15 2 80 16252 
27.90 27.87 33.12 40.91 38.46 50.00 34.33 
Other 4677 78 14 1 2 0 14 4786 
8.18 15.42 8.92 4.55 5.13 0.00 6.01 
White 36551 287 91 12 22 2 139 37104 
63.92 56.72 57.96 54.55 56.41 50.00 59.66 
Insured 
Private 20838 126 32 2 10 0 54 21062 
Insured 36.44 24.90 20.38 9.09 25.64 0.00 23.18 
Public 13900 78 27 2 7 2 67 14083 
Insured 24.31 15.42 17.20 9.09 17.95 50.00 28.76 
Uninsured 22443 302 98 18 22 2 112 22997 
39.25 59.68 62.42 81.82 56.41 50.00 48.07 
Total 57181 506 157 22 39 4 233 58142 
systems. For code = 0, age group "50-", race = "white", and Insured = "uninsured" have 
the highest percent number, 39.63%, 63.92% and 39.25% ,respectively; For code = 6, 
age group "50-59", race = "white", and Insured = "uninsured" have the highest % like, 
35.19%, 59.66% and 48.07% , respectively; It is partially due to the uneven percentage of 
people coming to screen (Table 2). Besides, Chi-square tests were performed to test the 
association. For all three categorical variables, P values are less than 0.001, which 
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provide strong evidence of an association between "code (pathology code)" and all other 
three categorical variables (age group/race/insured). Because majority of people do not 
need biopsy (code=O), only 961 women are diagnosed with the other codes. Chi-square 
tests also were performed and all P values are less than 0.05 «0.001 for "agegroup", 
















Figure 11. Trenn of screen disparities on age group of each race at code=6 
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Figure 10 and 11 show the trend of disparities of age group with different race at 
code = 0 and 6. The highest and lowest frequencies for code= 0 are 13948 for "white" 
younger than 50, 243 for "other" older than 70; for code = 6, they are 52 for "white" aged 
50-59, 1 for "other" aged 60-69. 
12000 













P uD lic In .. ,yr.d 












V- I'" 1/ 
I.-' 60 





Pub lio Inso r.d 
tn-sul' e d 
U n i ns ure d 
Figure 13. Trend of screen disparities on age group of each insurance at code=6 
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Table 4 
Summary of patients for De-identified breast cancer screen data 
I Variable Value Frequency Percent of Total 
Count Frequen~ 
Insured Uninsured 9289 41.2844 
Private Insured 8107 36.0311 
Public Insured 5104 22.6844 
Location PARTNERSHIP CLINIC 9319 41.4178 
CORPORATE 7700 34.2222 
PARTNERSHIP 5481 24.3600 
COMMUNITY 
Pc ode 0 21713 96.5022 
1 412 1.8311 
6 199 0.8844 
2 136 0.6044 
4 31 0.1378 
3 6 0.0267 
5 3 0.0133 
agegroup 50- 9888 43.9467 
50-59 6990 31.0667 
60-69 3476 15.4489 
70+ 2146 9.5378 
race White 14339 63.7289 
Black 6003 26.6800 
Other 2158 9.5911 
year 2006 2579 11.4622 
2002 2423 10.7689 
2005 2415 10.7333 
2001 2358 10.4800 
2004 2335 10.3778 
2003 2316 10.2933 
2010 2275 10.1111 
2007 2208 9.8133 
-
·2009 1881 8.3600 
1
2008 1710 7.6000 
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Figure 12-13 are the diagrams of trend of disparities of age group with different 
insurance at code = 0 and 6 respectively. For both codes, all the highest and lowest screen 
frequencies happened in categorical variable "Insured "= Uninsured. They are 10994 for 
women younger than 50 and 152 for women older than 70 at code=O; 52 for women aged 
50-59 and 3 for women older than 70 at code = 6. 
Although a total number of screen is 58142, actually only 22500 individuals 
participant the program. Because some women have multiple screens where different 
result might exist for each one, for each woman, only the case with maximum pathology 
code was chosen for analysis. The summary of patients is present as Table 4. 
Table 5 
Odds ratio of Race/Insurance for different age group 
Insurance odds ratio 
Age group Race Yes No Total 95% C. I. 
50-
White 3410 2584 5994 1.6686 
1199 1516 2715 
(1.5228, 1.8282) 
Black P < 0.0001 
Total 4609 4100 8709 
50-59 
White 2711 1833 4544 
1.8572 
833 1046 1879 
(1.666,2.0703) 
Black P < 0.0001 
Total 3544 2879 6423 
60-69 
White 1582 713 2295 
0.9893 
628 280 908 
(0.8377, 1.1682) 
Black p= 0.8988 
Total 2210 993 3203 
70+ 
White 1488 47 1535 0.3776 
503 6 509 
(0.1605, 0.8886) 
Black P = 0.0205 
Total 1991 53 2044 
Table 4 shows white and black women are the majority (~90% of population), so 
next we focus our analysis on this part of population. We replace variable "Insured" with 
"Insurance", combine "Private insured" and "Public insured" into Insurance = "yes", and 
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define "Uninsured" as Insurance = "No". We also change "Pathology_code" into 
"Pathology Jesult", and combine 0-3 into Pathology Jesult = "Negative" and 4-6 into 
Pathology Jesult = "Positive". There are 20342 women left for analysis. 
Table 6 
Odds ratio of Race/Pathology result for different age group 
Pathology_ Result odds ratio 
Age group Race Negative Positive Total 95% C. I. 
j 
50-
White 5954 40 5994 
0.9379 
I 2698 17 2715 
(0.5308, 1.6573) 
I Black P = 0.8253 
I 
Total 8652 57 8709 
50-59 
White 4465 50 4515 
1.2584 
1845 26 1871 
(0.7810, 2.0276) 
Black P = 0.3439 
Total 6310 76 6386 
60-69 
White 2262 33 2295 
1.3078 
891 17 908 
(0.7248,2.3599) 
I Black P = 0.3715 
I Total 3153 50 3203 
70+ 
t White 1521 14 1535 
4.4435 
L' 489 20 509 
(2.2275, 8.8638) 
Black P<O.OOOI 
Total 2010 34 2044 
Tables 5-7 present the calculated odds ratios and their 95% confidence intervals. 
Table 5 shows age groups "50-" and "50-59" have odds ratio of 1.6686 and 1.8572 which 
means the odds of white people with insurance is <2 times of black people with insurance 
for those two age groups. Age group "70+" is opposite, the odds of white women with 
insurance is only 0.4 time of black women with insurance. No much difference was found 
in odds between black and white for age group "60-69". From table 6, the significant 
result is only for age group "70+", the odds ratio is 4.4, so the odds of white women with 
"Negative" pathology result is 4.4 times of black women. There is not much difference 
for other age groups. Table 7 is the odds ratio of InsurancelPathology JesuIt. The two 
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non-significant age groups are "60-69" and "70+", for other age groups, the odds ratios 
are 2.26 for "50-", and 2.08 for "50-59". The odds of women with insurance "Yes" 
having "Negative" pathology result is 2.26/2.08 times of the women with insurance "No" 
for age group "50-", "50-59" respectively. 
Table 7 
Odds ratio of Insurance/Pathology result for different age group 
I Pathology_ Result odds ratio 
Ae grou~ Insurance Negative Positive Total 95% C. I. 
50- Yes 4590 19 4609 2.26 
4062 38 4100 
(1.3009,3.9262) 
No P = 0.003 
Total 8652 57 8709 
50-59 Yes 3632 30 3662 2.0796 
2678 46 2724 
(1.3093,3.3029) 
No P = 0.0015 
Total 6310 76 6386 
60-69 Yes 2179 31 2210 1.3712 
974 19 993 
(0.7708,2.4392) 
No P = 0.2809 
Total 3153 50 3203 
70+ Yes 1959 32 1991 2.4007 
51 2 53 
(0.5601, 10.2896) 
No P = 0.2236 
Total 2010 34 2044 
~ 
Tables 8 and 9 are the follow- up study. N is the number of screens for an 
individual. The maximum number that each person can take the screen from this data set 
is N=17. The majority (45%) only take screen once. About 19% of women take twice, 
12% take triple. Only one person took 17 times. Pearson and Spearman correlation 
coefficients were calculated to check the association. For agegroup by N, Person 
coefficient is 0.0605 with 95% C.1. (0.0477,0.0733) and Spearman coefficient is 0.0714 
with 95% C. I. (0.0584, 0.0844), which show a weakly positive association between 
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agegroup and~; Pearson and Spearman correlation coefficients for race by N are -0.0152 
with 95% C.I (- 0.0284, - 0.002) and - 0.0146 with 95% C.l. (- 0.0277, -0.0014) 
respectively, which means a weakly negative association. Pearson and Spearman 
correlation coefficients for Insured byN are -0.0288 with 95% C.I (- 0.0419, - 0.0156) 
and - 0.0019 with 95% C.I (-0.0149,0.0112) respectively, there is no association between 
them. For pathology code by N,.Pearson and Spearman correlation coefficients are 
0.1701 with 95% C.I (0.1539,0.1863) and 0.2154 with 95% C. I (0.2051, 0.2257) 





Summary of screen numbers for each agegroup/racelinsured 
r----·--------
Age group N (SCREEN NUMBER) 
I 2 3 4 5 -r--6 7 8 9 10 
50- 4771 1951 1244 659 439 290 202 123 85 59 
21.20 8.67 5.53 2.93 1.95 1.29 0.90 0.55 0.38 0.26 
50-59 2948 1276 916 614 382 290 199 128 93 88 
13.10 5.67 4.07 2.73 1.70 1.29 0.88 0.57 0.41 0.39 
60-69 1402 639 400 317 226 187 110 80 40 44 
6.23 2.84 1.78 1.41 1.00 0.83 0.49 0.36 0.18 0.20 
70+ 978 407 256 159 121 75 59 43 23 13 
4.35 1.81 1.14 0.71 0.54 0.33 0.26 0.19 0.10 0.06 
Race 
Black 2521 1147 772 514 330 275 175 113 70 40 
11.20 5.10 3.43 2.28 1.47 1.22 0.78 0.50 0.31 0.18 
_. 
Other 1138 379 256 132 93 61 38 32 10 7 
5.06 1.68 1.14 0.59 0.41 0.27 0.17 0.14 0.04 0.03 
White 6440 2747 1788 1103 745 506 357 229 161 157 
28.62 12.21 7.95 4.90 3.31 2.25 1.59 1.02 0.72 0.70 
Insured 
Private 3815 1473 940 536 375 299 216 141 110 118 
Insured 16.96 6.55 4.18 2.38 1.67 1.33 0.96 0.63 0.49 0.52 
Public 2099 932 662 496 335 220 139 102 52 39 
Insured 9.33 4.14 2.94 2.20 1.49 0.98 0.62 0.45 0.23 0.17 
r---
Uninsured 4185 1868 1214 717 458 323 215 131 79 47 
18.60 8.30 5.40 3.19 2.04 1.44 0.96 0.58 0.35 0.21 
Total 10099 4273 2816 1749 1168 842 570 374 241 204 
44.88 18.99 12.52 7.77 5.19 3.74 2.53 1.66 1.07 0.91 
---- -_ ... _--- - L-___ - -_._-- ----
--
-
II 12 13 14 15 16 17 Total 
29 17 8 5 3 2 1 9888 
0.13 0.08 0.04 0.02 0.01 0.01 0.00 43.95 
29 II 7 4 3 2 0 6990 
0.13 0.05 0.03 0.02 0.01 0.01 0.00 31.07 
19 3 6 2 I 0 0 3476 
0.08 0.01 0.03 0.01 0.00 0.00 0.00 15.45 
7 4 I 0 0 0 0 2146 
0.03 0.02 0.00 0.00 0.00 0.00 0.00 9.54 
22 14 3 4 I 2 0 6003 
0.10 0.06 0.01 0.02 0.00 0.01 0.00 26.68 
5 I 3 I 2 0 0 2158 
0.02 0.00 0.01 0.00 0.01 0.00 0.00 9.59 
57 20 16 6 4 2 1 14339 
0.25 0.09 0.07 0.03 0.02 O.oJ 0.00 63.73 
41 24 6 8 3 2 0 8107 
0.18 0.11 0.03 0.04 0.01 0.01 0.00 36.03 
19 3 6 0 0 0 0 5104 
0.08 0.01 0.03 0.00 0.00 0.00 0.00 22.68 
24 8 10 3 4 2 1 9289 
0.11 0.04 0.04 0.01 0.02 0.01 0.00 41.28 
84 35 22 II 7 4 1 22500 




Summary of screen numbers vs. pathology code 
Pathology code 
I 2 3 4 5 6 
0 10082 4200 2669 1585 1061 766 
44.81 18.67 11.86 7.04 4.72 3.40 
I 11 42 87 79 57 41 
0.05 0.19 0.39 0.35 0.25 0.18 
2 2 6 15 28 16 12 
0.01 0.03 0.07 0.12 0.07 0.05 
3 0 0 0 I 0 2 
0.00 0.00 0.00 0.00 0.00 0.01 
4 0 2 7 7 4 4 
0.00 0.01 0.03 0.03 0.02 0.02 
5 0 I 0 1 0 1 
0.00 0.00 0.00 0.00 0.00 0.00 
6 4 22 38 48 30 16 
0.02 0.10 0.17 0.21 0.l3 0.07 
Total 10099 4273 2816 1749 1168 842 


















N (screen times) 
9 10 II 12 l3 14 15 16 17 Total 
215 179 64 26 14 8 4 I 0 21713 
0.96 0.80 0.28 0.12 0.06 0.04 0.02 0.00 0.00 96.50 
12 13 10 I 4 I 1 I 0 412 
0.05 0.06 0.04 0.00 0.02 0.00 0.00 0.00 0.00 1.83 
9 6 5 6 4 I I I 1 136 
0.04 0.03 0.02 0.03 0.02 0.00 0.00 0.00 0.00 0.60 
0 I 0 0 0 0 0 0 0 6 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 
I 1 1 I 0 0 0 0 0 31 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 
0 0 0 0 0 0 0 0 0 3 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 
4 4 4 1 0 1 1 1 0 199 
0.D2 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.88 
241 204 84 35 22 11 7 4 I 22500 
1.07 0.91 0.37 0.16 0.10 _ 0.05 0.03 0.02 0.00 100.00 
CHAPTER IV 
CONCLUSION 
This de-identified breast cancer screen data set includes the information of 22534 
women and 58231 screens from 2001-2010. Two parts of analysis have been done with 
this data. At first, the trend and disparities in the diagnosis of breast cancer by mobile 
mammography between age, race, insurance system and screen location over the years 
based on screen number are analyzed. After removing 10 missing or bad data, there are 
58221 screens for analysis. We found: (1) For age group, women younger than 50 are 
more likely to take the screen and comprise 40% of the screens, aged group from 50-59 is 
the next and comprise 32.75% of the screen, then followed by age group 60-69 (17.70%), 
women older than 70 years is the least (9.86%). (2) For race, 64% of screens are taken 
by white, 30% by black, and only 8% by the others. (3) For insurance system, it is 
surprised that the women without insurance take 40% of screens, then the private insured 
women which is 36%, public insured women contribute only 24%. (4) For location, 
people are more likely to go to partnership clinic (43.49%), then corporate (33.23%). The 
last one is partnership community (23.29%). The year of 2006 has the highest number of 
screens which is 6861 and 2001 has the lowest number of 4813. Over the years, the trend 
of age group for three different races are similar, the older the age, the less the screen 
frequency (Figures 1-3); the pattern of age group for three different insurance system are 
not the same. The pattern of "public insured" is opposite to "Private insured" and 
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"Uninsured". The reason partially is that "Public insured" (medicare and medicaid) 
aralways issued to old women (Figures 4-6); All three different locations "corporate", 
"partnership clinic", and "partnership community" have similar trends for all age groups 
over the 10 years. As shown in Figures 7-9, except few cases, it generally follows the rule: 
the older, the fewer screens. The disparities of pathology results of screens based on 
different insurance system, age groups, and races have also been analyzed in this study 
(Table 3). For code = 0, age group "50-", race = "white", and Insured = "uninsured" have 
the highest percent numbers, 39.63%, 63.92% and 39.25% , respectively under each 
categorical variable; For code = 6, age group "50-59", race = "white", and Insured = 
"uninsured" have the highest % like, 35.19%, 59.66% and 48.07%. Besides, Chi-square 
tests were performed to test the association. For all three categorical variables, P values 
are less than 0.001, which provide strong evidence of an association between "code 
(pathology code)" and all other three categorical variables "agegroup", "race", and 
"Insured". The trend studies are to check the patterns between race/insurance system of 
all age groups for each specific pathology code (Figures 1 0-13). 
As mentioned before, there are 22534 individuals participant the program, the 
odds ratio analysis is done on white and black women only because they are the majority 
of participants (90%). some women have multiple screens with multiple pathology codes. 
For each woman, only the case with maximum pathology code was chosen for odds ratio 
calculation. There are 20342 women left for analysis. The calculated odds ratios and 
their 95% confidence intervals are present in Tables 5-7. Basically, for race/insurance, in 
age groups "50-", "50-59"and '70+', the odds of white people with insurance is 1.7, 1.9, 
and 0.4 times of black people with insurance respectively. No much difference in odds 
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was found in age group "60-69". F or race/pathology_result, the significant result is only 
for age group "70+", the odds of white women with "Negative" pathology result is 4.4 
times of black women with "Negative" pathology result. Besides, for insurance/pathology 
result, the odds of women with insurance "Yes" having "Negative" pathology result are 
2.26 and 2.08 times of the women with insurance "Yes" having "Negative" pathology 
result for age group "50-" and "50-59". The follow-up study was performed based on 
22500 women (34 of22534 with missing information). The maximum number that each 
person took the screen for this data set is 17. The majority (45%) only take screen once. 
About 19% of women took twice, 12% took triple. Only one woman took 17 times. 
Pearson and Spearman correlation coefficients were calculated to check the association. 




Race/insurance to pathology result for different age group 
Insurance Pathology Result 
Age (Yes="Public Insured" or 
group Race "Private Insured"; No= Positive Negative Odds 
"Uninsured") (code=0-3) (code=4-6) Ratio 
50- White Yes 15 3395 0.45 
No 25 2559 
Black Yes 4 1195 0.39 
I No 13 1503 
50-59 White Yes 22 2739 0.50 
No 28 1726 
Black Yes 8 893 0.47 
No 18 952 
60-69 I 
I 
White Yes 21 1561 0.79 
I No 12 701 
f---- ----
I Black Yes 10 618 0.63 
No 7 273 
r--
70+ White Yes 12 1476 0.18 
No 2 45 
~-
I 
Black Yes 20 483 #DIV/O! 
-
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